Natarajan Rajesh 4

What Happened Rajesh Natarajan, a director of HealthEquity, Inc. (HQY), was awarded 976 restricted stock units (RSUs) on February 2, 2026. The RSUs are reported as an acquisition (code A) at $0.00 per share (total reported value $0). Under the grant, 244 RSUs vested immediately on February 2, 2026; the remaining 732 RSUs vest in three equal tranches of 244 shares on the first day of May, August, and November 2026. Vested shares will be delivered to Mr. Natarajan on the earlier of February 1, 2033, a change in control (as defined in the company’s 2024 equity incentive plan), the reporting person’s termination of service, or the reporting person’s death.

Key Details

• Transaction date: 2026-02-02 (filed on 2026-02-04); transaction code: A (award/grant). Filing appears timely.
• Amount: 976 RSUs awarded at $0.00 per share (reported value $0); 244 RSUs vested immediately.
• Vesting schedule for remaining RSUs: 244 shares vest each on May 1, Aug 1, and Nov 1, 2026.
• Delivery timing: Vested shares delivery deferred until earlier of Feb 1, 2033, change of control, termination, or death (per footnote).
• Shares owned after the transaction: not specified in the filing.
• Administrative note: A previously filed Power of Attorney for Mr. Natarajan is incorporated by reference.

Context Restricted stock units are a form of equity compensation representing a contingent right to receive shares upon vesting and any plan-specified delivery conditions; they are not the same as an open-market purchase. Grants like this are routine compensation and do not, by themselves, indicate insider buying or selling sentiment.